4DMedical Limited (4DX.AX)
AUD 0.3
(17.65%)
AUD 0.3
(17.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 49.08 Million AUD | 128.71% |
| 2023 | 21.46 Million AUD | 45.0% |
| 2022 | 14.8 Million AUD | 59.51% |
| 2021 | 9.28 Million AUD | -66.42% |
| 2020 | 27.63 Million AUD | 518.43% |
| 2019 | 4.46 Million AUD | 166.89% |
| 2018 | 1.67 Million AUD | -1.31% |
| 2017 | 1.69 Million AUD | 924.05% |
| 2016 | 165.65 Thousand AUD | 16.08% |
| 2015 | 142.71 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 49.08 Million AUD | 0.0% |
| 2024 Q1 | 52.6 Million AUD | 145.08% |
| 2024 Q2 | 52.6 Million AUD | 0.0% |
| 2024 Q3 | 49.08 Million AUD | -6.68% |
| 2024 FY | 49.08 Million AUD | 128.71% |
| 2023 Q3 | 21.46 Million AUD | -2.69% |
| 2023 FY | 21.46 Million AUD | 45.0% |
| 2023 Q4 | 21.46 Million AUD | 0.0% |
| 2023 Q2 | 22.05 Million AUD | 0.0% |
| 2023 Q1 | 22.05 Million AUD | 49.01% |
| 2022 Q1 | 6.22 Million AUD | -32.91% |
| 2022 FY | 14.8 Million AUD | 59.51% |
| 2022 Q4 | 14.8 Million AUD | 0.0% |
| 2022 Q3 | 14.8 Million AUD | 137.75% |
| 2022 Q2 | 6.22 Million AUD | 0.0% |
| 2021 FY | 9.28 Million AUD | -66.42% |
| 2021 Q2 | 3.63 Million AUD | 0.0% |
| 2021 Q1 | 3.63 Million AUD | -86.84% |
| 2021 Q3 | 9.28 Million AUD | 155.23% |
| 2021 Q4 | 9.28 Million AUD | 0.0% |
| 2020 Q4 | 27.63 Million AUD | 0.0% |
| 2020 Q1 | 19.33 Million AUD | 332.78% |
| 2020 FY | 27.63 Million AUD | 518.43% |
| 2020 Q2 | 19.33 Million AUD | 0.0% |
| 2020 Q3 | 27.63 Million AUD | 42.9% |
| 2019 FY | 4.46 Million AUD | 166.89% |
| 2019 Q4 | 4.46 Million AUD | 0.0% |
| 2019 Q3 | 4.46 Million AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2018 FY | 1.67 Million AUD | -1.31% |
| 2017 FY | 1.69 Million AUD | 924.05% |
| 2016 FY | 165.65 Thousand AUD | 16.08% |
| 2015 FY | 142.71 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Adherium Limited | 3.4 Million AUD | -1340.924% |
| Aroa Biosurgery Limited | 14.77 Million AUD | -232.161% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -3692.418% |
| Anteris Technologies Ltd | 17.03 Million AUD | -188.094% |
| Control Bionics Limited | 2.75 Million AUD | -1678.836% |
| CardieX Limited | 8.56 Million AUD | -473.312% |
| Compumedics Limited | 22.14 Million AUD | -121.64% |
| Cochlear Limited | 904.6 Million AUD | 94.573% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -606.342% |
| Cyclopharm Limited | 13.65 Million AUD | -259.501% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -799.777% |
| Nova Eye Medical Limited | 8.55 Million AUD | -474.004% |
| HeraMED Limited | 1.5 Million AUD | -3159.682% |
| Imricor Medical Systems, Inc. | 25 Million AUD | -96.321% |
| ImpediMed Limited | 6.24 Million AUD | -686.301% |
| InhaleRx Limited | 911.41 Thousand AUD | -5286.009% |
| LBT Innovations Limited | 5.5 Million AUD | -791.227% |
| Micro-X Limited | 12.63 Million AUD | -288.545% |
| Neurotech International Limited | 314.69 Thousand AUD | -15498.648% |
| OncoSil Medical Limited | 1.98 Million AUD | -2376.738% |
| PolyNovo Limited | 37.04 Million AUD | -32.518% |
| Respiri Limited | 3.55 Million AUD | -1281.236% |
| SomnoMed Limited | 24.78 Million AUD | -98.094% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -362.554% |
| Uscom Limited | 2.07 Million AUD | -2267.351% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -1674.138% |